市場調査レポート
商品コード
1083116

細胞解析の世界市場:製品・サービス(試薬・消耗品、装置)、技術(フローサイトメトリー、ハイコンテントスクリーニング)、プロセス(単一細胞解析)、エンドユーザー(製薬企業、バイオテクノロジー企業)別 - 2027年までの予測

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) - Global Forecast to 2027

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 228 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
細胞解析の世界市場:製品・サービス(試薬・消耗品、装置)、技術(フローサイトメトリー、ハイコンテントスクリーニング)、プロセス(単一細胞解析)、エンドユーザー(製薬企業、バイオテクノロジー企業)別 - 2027年までの予測
出版日: 2022年05月31日
発行: MarketsandMarkets
ページ情報: 英文 228 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の細胞解析の市場規模は、予測期間中の10.1%のCAGRで推移し、2022年の177億米ドルから、2027年までに286億米ドルに達すると予測されています。

市場の主な機会には、新興経済、伝染病やパンデミック発生のリスクの高さ、様々ながん研究用途における新たな細胞アッセイの採用増加などが挙げられます。一方、細胞解析装置に関するコストの高さや、実験に使用する試薬の制限などが、市場成長を抑制する要因になると予想されます。

当レポートでは、世界の細胞解析市場について調査し、市場力学、セグメント・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • ポーターのファイブフォース分析
  • COVID-19が細胞解析市場に与える影響
  • サプライチェーン分析
  • バリューチェーン分析
  • エコシステム分析
  • 規制分析(フローサイトメトリーベースの細胞解析)
  • 技術分析
  • 主な会議とイベント(2021-2022)
  • 価格分析

第6章 製品・サービス別:細胞解析市場

  • 試薬・消耗品
  • 装置
  • 付属品
  • ソフトウェア
  • サービス

第7章 技術別:細胞解析市場

  • フローサイトメトリー
  • PCR
  • セルマイクロアレイ
  • 顕微鏡
  • 分光光度法
  • ハイコンテントスクリーニング(HCS)
  • その他のテクニック

第8章 プロセス別:細胞解析市場

  • 細胞の識別
  • 細胞生存度
  • 細胞シグナル伝達経路/シグナル伝達
  • 細胞増殖
  • 細胞のカウントと品質管理
  • 細胞間相互作用
  • 細胞構造研究
  • ターゲットの識別と検証
  • 単一細胞解析

第9章 エンドユーザー別:細胞解析市場

  • 製薬・バイオテクノロジー企業
  • 病院・臨床試験ラボ
  • 学術・研究機関
  • その他

第10章 地域別:細胞解析市場

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 主要企業によって採用された成功へのアプローチ
  • 市場シェア分析
  • 収益シェア分析(主要市場参入企業7社)
  • 企業評価クアドラント
  • 競合リーダーシップマッピング:新興企業/中小企業/スタートアップ(2021)
  • 競合シナリオと動向

第12章 企業プロファイル

  • 主要企業
    • THERMO FISHER SCIENTIFIC INC.
    • DANAHER
    • BECTON, DICKINSON AND COMPANY(BD)
    • GENERAL ELECTRIC
    • MERCK KGAA
    • AGILENT TECHNOLOGIES, INC.
    • BIO-RAD LABORATORIES, INC.
    • FLUIDIGM CORPORATION
    • MILTENYI BIOTEC
    • OLYMPUS CORPORATION
    • BIOSTATUS LIMITED
    • NANOCELLECT BIOMEDICAL
    • CELL BIOLABS, INC.
    • CREATIVE BIOARRAY
    • MEIJI TECHNO
  • その他の企業
    • PROMEGA CORPORATION
    • PERKINELMER
    • TECAN TRADING AG
    • CARL ZEISS
    • SYSMEX AMERICA, INC.
    • CELLINK
    • QIAGEN
    • ILLUMINA, INC.
    • CORNING INCORPORATED
    • 10X GENOMICS

第13章 付録

目次
Product Code: BT 2358

The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand,high costs associated with cell analysis instruments along with limitations on the usage of reagents for experiments is expected to restrain the market growth.

"The reagents & consumables segment dominates the cell analysis market through the study period of 2020-2027."

Based on product & service, the global cell analysis market is segmented into reagents & consumables, instruments, accessories, software, and services. The reagents & consumables segment represented largest market share for the year 2021, in cell analysis market. Development of affordable reagent solutions by key market players is the key attributive factor to the segment's dominance. This is further supplemented by increasing demand for novel cell analysis reagents & consumables in flow cytometry experiments.

"The high content screening (HCS) segment will witness the highest growth in the cell analysis market during the forecast period."

Based on technique, the global cell analysis market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening (HCS), and other techniques. HCS techniquecombineshigh-throughput automated imaging with analysis which helps inthe extraction of single-cell data, multi-parametric in nature. In addition, widening applications of HCS have contributed to the robust CAGR registered by this segment from 2022-2027.

"North America dominated the cell analysis market in 2021."

Geographically, the cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share of the cell analysis market. North America harbors majority of the key market players leading to maturity of cell analysis market in this region. Also, robust government support for academic & research activities offer opportunity for the key market players to introduce cutting-edge cell analysis products, further intensifying regional market competition.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type -Tier 1: 37%, Tier 2: 23%,and Tier 3: 40%
  • By Designation - C-level:32%, D-level:26%, and Others:42%
  • By Region - North America:35%, Europe:25%, Asia Pacific:20%, Latin America: 12%, and the Middle East and Africa: 8%

List of Companies Profiled in the Report

  • Danaher (US)
  • Thermo Fisher Scientific (US)
  • BectonDickinson and Company (US)
  • General Electric (US)
  • Merck KGaA (US)
  • Agilent Technologies (US)
  • Olympus Corporation (Japan)
  • MiltenyiBiotec (US)
  • Bio-Rad Laboratories (US)
  • BioStatus Limited (UK)
  • Fluidigm Corporation (US)
  • NanoCellect Biomedical (US)
  • Cell Biolabs (US)
  • Creative Bioarray (US)
  • Meiji Techno (US)
  • Promega Corporation (US)
  • PerkinElmer (US)
  • Tecan Trading AG (Switzerland)
  • CELLINK (US)
  • QIAGEN (Germany)
  • Corning Incorporated (US)
  • 10x Genomics (US)
  • Illumina (US)

Research Coverage:

This report provides a detailed picture of the global cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product& service,technique, process, end user,and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell analysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on cell analysis offered by the top 25 players in the cell analysis market. The report analyses the cell analysis market by product& service,technique, process, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell analysis across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell analysis market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the cell analysis market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 CELL ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE)
    • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
    • FIGURE 5 AVERAGE MARKET SIZE ESTIMATION (2021)
  • 2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • FIGURE 6 CELL ANALYSIS MARKET: CAGR PROJECTIONS (2022-2027)
    • FIGURE 7 CELL ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 INSIGHTS FROM PRIMARIES
    • FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
  • 2.6 RESEARCH ASSUMPTIONS
    • 2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 CELL ANALYSIS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 CELL ANALYSIS MARKET, BY PROCESS, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 CELL ANALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE CELL ANALYSIS MARKET

4 PREMIUM INSIGHTS

  • 4.1 CELL ANALYSIS MARKET OVERVIEW
    • FIGURE 15 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: CELL ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2021)
    • FIGURE 16 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
  • 4.3 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 17 FLOW CYTOMETRY SEGMENT WILL CONTINUE TO DOMINATE NORTH AMERICAN MARKET IN 2027

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
    • TABLE 1 CELL ANALYSIS MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising preference for cell-based assays in drug discovery
      • 5.2.1.2 Increasing funding for cell-based research
      • 5.2.1.3 Growing number of drug discovery activities
    • 5.2.2 RESTRAINT
      • 5.2.2.1 High cost of instruments and restrictions on reagent use
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging economies
      • 5.2.3.2 Growing risk of pandemics and communicable diseases
      • 5.2.3.3 Application of novel cell-based assays in cancer research
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 DEGREE OF COMPETITION
  • 5.4 IMPACT OF COVID-19 ON THE CELL ANALYSIS MARKET
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 19 CELL ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS (CELL-BASED ASSAYS)
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 20 CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 21 CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
  • 5.8 REGULATORY ANALYSIS (FLOW CYTOMETRY-BASED CELL ANALYSIS)
    • 5.8.1 STRINGENT FDA REQUIREMENTS
    • 5.8.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
    • 5.8.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
    • 5.8.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
    • 5.8.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
    • 5.8.6 US REIMBURSEMENT SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • FIGURE 22 TECHNOLOGY ANALYSIS: CELL ANALYSIS MARKET
  • 5.10 KEY CONFERENCES & EVENTS, 2021-2022
    • 5.10.1 CELL ANALYSIS CONFERENCES, 2022
    • TABLE 3 CELL ANALYSIS CONFERENCES (2022)
    • 5.10.2 CELL ANALYSIS CONFERENCES, 2021
    • TABLE 4 CELL ANALYSIS CONFERENCES (2021)
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES
    • TABLE 5 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES (TOP 5)
    • 5.11.2 AVERAGE SELLING PRICE TREND

6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
  • 6.2 REAGENTS & CONSUMABLES
    • 6.2.1 ADVENT OF NOVEL CELL ANALYSIS KITS & REAGENTS FOR FLOW CYTOMETRY TO BOOST SEGMENT GROWTH
    • TABLE 7 CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 8 NORTH AMERICA: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 9 EUROPE: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 10 ASIA PACIFIC: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 INSTRUMENTS
    • 6.3.1 INNOVATIONS IN CELL ANALYSIS INSTRUMENTS FOR DRUG DISCOVERY RESEARCH TO DRIVE MARKET GROWTH
    • TABLE 11 CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 12 NORTH AMERICA: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 13 EUROPE: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 14 ASIA PACIFIC: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.4 ACCESSORIES
    • 6.4.1 FLOW CYTOMETRY ACCESSORIES ENABLE END USERS TO CUSTOMIZE FLOW CYTOMETRY INSTRUMENTS
    • TABLE 15 CELL ANALYSIS ACCESSORIES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 16 NORTH AMERICA: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 17 EUROPE: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 18 ASIA PACIFIC: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.5 SOFTWARE
    • 6.5.1 EXPANDING POOL OF KEY PLAYERS INTRODUCING UNIQUE SOFTWARE OR DATA INTERPRETATION TOOLS PROPELS SEGMENT GROWTH
    • TABLE 19 CELL ANALYSIS SOFTWARE MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 20 NORTH AMERICA: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 21 EUROPE: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 22 ASIA PACIFIC: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.6 SERVICES
    • 6.6.1 REMOTE SERVICES ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE
    • TABLE 23 CELL ANALYSIS SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 24 NORTH AMERICA: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 25 EUROPE: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 CELL ANALYSIS MARKET, BY TECHNIQUE

  • 7.1 INTRODUCTION
    • TABLE 27 CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  • 7.2 FLOW CYTOMETRY
    • 7.2.1 ABILITY TO PERFORM MULTIPLE MEASUREMENTS ON SINGLE CELLS IS KEY ADVANTAGE ASSOCIATED WITH THIS TECHNIQUE
    • TABLE 28 CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 29 NORTH AMERICA: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 30 EUROPE: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 PCR
    • 7.3.1 DIGITAL PCR CAN EFFECTIVELY MEASURE AND MONITOR RARE SEQUENCES
    • TABLE 32 CELL ANALYSIS MARKET FOR PCR, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 33 NORTH AMERICA: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 34 EUROPE: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.4 CELL MICROARRAYS
    • 7.4.1 CELL MICROARRAYS ARE USED IN DESIGNING AND CONTROLLING STEM CELLS IN TISSUE ENGINEERING
    • TABLE 36 CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 37 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 38 EUROPE: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.5 MICROSCOPY
    • 7.5.1 RISING INCIDENCE OF CANCER AND GROWING INVESTMENTS IN CELL BIOLOGY TO DRIVE MARKET GROWTH
    • TABLE 40 CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 41 NORTH AMERICA: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 42 EUROPE: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.6 SPECTROPHOTOMETRY
    • 7.6.1 HIGH DEMAND FOR SPECTROPHOTOMETERS IN RESEARCH SETTINGS TO SUPPORT MARKET GROWTH
    • TABLE 44 CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 46 EUROPE: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.7 HIGH-CONTENT SCREENING (HCS)
    • 7.7.1 HIGH DEMAND FOR HCS IN CELL BEHAVIOR RESEARCH STUDIES TO SUPPORT SEGMENT GROWTH
    • TABLE 48 CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 49 NORTH AMERICA: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 50 EUROPE: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.8 OTHER TECHNIQUES
    • TABLE 52 CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 53 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 54 EUROPE: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020-2027 (USD MILLION)

8 CELL ANALYSIS MARKET, BY PROCESS

  • 8.1 INTRODUCTION
    • TABLE 56 CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
  • 8.2 CELL IDENTIFICATION
    • 8.2.1 INCREASING RESEARCH ACTIVITIES TO PROPEL MARKET GROWTH
    • TABLE 57 CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 58 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 59 EUROPE: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 CELL VIABILITY
    • 8.3.1 CELL VIABILITY IS USED TO CORRELATE CELL BEHAVIOR TO CELL NUMBERS
    • TABLE 61 CELL ANALYSIS MARKET FOR CELL VIABILITY, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 62 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION
    • 8.4.1 HIGH DEMAND FOR TOXICITY TESTING IN DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
    • TABLE 65 CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 66 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 67 EUROPE: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.5 CELL PROLIFERATION
    • 8.5.1 CELL PROLIFERATION IS MEASURED ON THE BASIS OF AVERAGE DNA CONTENT
    • TABLE 69 CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 70 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 71 EUROPE: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.6 CELL COUNTING & QUALITY CONTROL
    • 8.6.1 FLOW CYTOMETRY ENABLES EASY DIFFERENTIATION OF CELLS VIA SCATTERING OR STAINING
    • TABLE 73 CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 75 EUROPE: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.7 CELL INTERACTION
    • 8.7.1 INCREASING ADVANCEMENTS IN CELL-CELL INTERACTIONS/CELL-CELL COMMUNICATION TO BOOST MARKET GROWTH
    • TABLE 77 CELL ANALYSIS MARKET FOR CELL INTERACTION, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 78 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 79 EUROPE: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.8 CELL STRUCTURE STUDY
    • 8.8.1 ADVANCEMENTS IN CELLULAR IMAGING TO SUPPORT MARKET GROWTH
    • TABLE 81 CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 82 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 83 EUROPE: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.9 TARGET IDENTIFICATION & VALIDATION
    • 8.9.1 HCS IN TARGET IDENTIFICATION IS USED TO IDENTIFY NOVEL TARGETS THROUGH SCREENING OF CELLULAR PATHWAYS
    • TABLE 85 CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 86 NORTH AMERICA: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 87 EUROPE: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.10 SINGLE-CELL ANALYSIS
    • 8.10.1 EXPANDING APPLICATIONS OF SINGLE-CELL ANALYSIS IN CLINICAL RESEARCH TO PROPEL SEGMENT GROWTH
    • TABLE 89 CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 90 NORTH AMERICA: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 91 EUROPE: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020-2027 (USD MILLION)

9 CELL ANALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 93 CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 HIGH DEMAND FOR CELL-BASED RESEARCH IN DRUG DISCOVERY & DEVELOPMENT PROCESS CONTRIBUTES TO SEGMENT GROWTH
    • TABLE 94 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 95 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 96 NORTH AMERICA: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 97 EUROPE: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 98 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
    • 9.3.1 DEVELOPMENT OF COMPLEX & HIGHLY SPECIALIZED TESTS AND ASSAYS SUPPORTS MARKET GROWTH
    • TABLE 99 CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 100 NORTH AMERICA: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 101 EUROPE: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH
    • TABLE 103 CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 104 NORTH AMERICA: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 105 EUROPE: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 107 CELL ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 108 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 109 EUROPE: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)

10 CELL ANALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 111 CELL ANALYSIS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: CELL ANALYSIS MARKET SNAPSHOT
    • TABLE 112 NORTH AMERICA: CELL ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 113 NORTH AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 114 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 115 NORTH AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 116 NORTH AMERICA: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US dominates North American cell analysis market
    • TABLE 117 US: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 118 US: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 119 US: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 120 US: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing government initiatives targeted toward stem cell research to drive market growth
    • TABLE 121 CANADA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 122 CANADA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 123 CANADA: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 124 CANADA: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 125 EUROPE: CELL ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 126 EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 127 EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 128 EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 129 EUROPE: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Strong R&D infrastructure, training, and awareness programs ensure market growth in Germany
    • TABLE 130 GERMANY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 131 GERMANY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 132 GERMANY: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 133 GERMANY: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Presence of large biotechnology industry favors market growth
    • TABLE 134 FRANCE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 135 FRANCE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 136 FRANCE: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 137 FRANCE: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Growing acceptance of flow cytometry products for clinical diagnostics to drive market growth
    • TABLE 138 UK: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 139 UK: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 140 UK: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 141 UK: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing research activities and conferences to support market growth
    • TABLE 142 ITALY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 143 ITALY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 144 ITALY: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 145 ITALY: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growing focus on cancer diagnosis increased flow cytometry product usage in Spain
    • TABLE 146 SPAIN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 147 SPAIN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 148 SPAIN: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 149 SPAIN: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 150 REST OF EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 151 REST OF EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 152 REST OF EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 153 REST OF EUROPE: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: CELL ANALYSIS MARKET SNAPSHOT
    • TABLE 154 ASIA PACIFIC: CELL ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Easy access to technologically advanced cell analysis products to favor market growth
    • TABLE 159 JAPAN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 160 JAPAN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 161 JAPAN: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 162 JAPAN: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Developments in biotechnology sector to support market growth
    • TABLE 163 CHINA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 164 CHINA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 165 CHINA: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 166 CHINA: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Government initiatives to drive market growth in India
    • TABLE 167 INDIA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 168 INDIA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 169 INDIA: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 170 INDIA: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 171 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 172 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 173 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 174 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH
    • TABLE 175 LATIN AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 176 LATIN AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 177 LATIN AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 178 LATIN AMERICA: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 GROWING RESEARCH ACTIVITIES WILL FUEL DEMAND FOR CELL ANALYSIS PRODUCTS
    • TABLE 179 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 181 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PROCESS, 2020-2027 (USD MILLION)
    • TABLE 182 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 25 CELL ANALYSIS MARKET: STRATEGIES ADOPTED
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 26 CELL ANALYSIS MARKET SHARE ANALYSIS (2021)
  • 11.4 REVENUE SHARE ANALYSIS (TOP 7 MARKET PLAYERS)
    • FIGURE 27 REVENUE ANALYSIS FOR KEY COMPANIES, 2018-2021
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 28 CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, 2021
  • 11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/ SMES/ START-UPS (2021)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 29 CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021
  • 11.7 COMPETITIVE SCENARIO AND TRENDS
    • 11.7.1 PRODUCT LAUNCHES
    • TABLE 183 CELL ANALYSIS MARKET: PRODUCT LAUNCHES
    • 11.7.2 DEALS
    • TABLE 184 CELL ANALYSIS MARKET: DEALS
    • 11.7.3 OTHER DEVELOPMENTS
    • TABLE 185 CELL ANALYSIS MARKET: OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY COMPANIES
  • (Business Overview, Products Offered, Recent Developments, and MnM View)**
    • 12.1.1 THERMO FISHER SCIENTIFIC INC.
    • TABLE 186 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
    • TABLE 187 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
    • TABLE 188 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCH
    • TABLE 189 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 12.1.2 DANAHER
    • TABLE 190 DANAHER: BUSINESS OVERVIEW
    • FIGURE 31 DANAHER: COMPANY SNAPSHOT (2021)
    • TABLE 191 DANAHER: PRODUCT OFFERINGS
    • TABLE 192 DANAHER: DEALS
    • TABLE 193 DANAHER: OTHER DEVELOPMENTS
    • 12.1.3 BECTON, DICKINSON AND COMPANY (BD)
    • TABLE 194 BD: BUSINESS OVERVIEW
    • FIGURE 32 BD: COMPANY SNAPSHOT (2021)
    • TABLE 195 BD: PRODUCT OFFERINGS
    • TABLE 196 BD: PRODUCT LAUNCH
    • 12.1.4 GENERAL ELECTRIC
    • TABLE 197 GE: BUSINESS OVERVIEW
    • FIGURE 33 GE: COMPANY SNAPSHOT (2021)
    • TABLE 198 GE: PRODUCT OFFERINGS
    • TABLE 199 GE HEALTHCARE: OTHER DEVELOPMENTS
    • 12.1.5 MERCK KGAA
    • TABLE 200 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2021)
    • TABLE 201 MERCK KGAA: PRODUCT OFFERINGS
    • TABLE 202 MERCK KGAA: DEALS
    • 12.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 203 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 35 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
    • TABLE 204 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
    • TABLE 205 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
    • 12.1.7 BIO-RAD LABORATORIES, INC.
    • TABLE 206 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
    • TABLE 207 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
    • TABLE 208 BIO-RAD LABORATORIES, INC.: DEALS
    • 12.1.8 FLUIDIGM CORPORATION
    • TABLE 209 FLUIDIGM CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2021)
    • TABLE 210 FLUIDIGM CORPORATION: PRODUCT OFFERINGS
    • TABLE 211 FLUIDIGM CORPORATION: DEALS
    • 12.1.9 MILTENYI BIOTEC
    • TABLE 212 MILTENYI BIOTEC: BUSINESS OVERVIEW
    • TABLE 213 MILTENYI BIOTEC: PRODUCT OFFERINGS
    • TABLE 214 MILTENYI BIOTEC: PRODUCT LAUNCHES
    • 12.1.10 OLYMPUS CORPORATION
    • TABLE 215 OLYMPUS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
    • TABLE 216 OLYMPUS CORPORATION: PRODUCT OFFERINGS
    • 12.1.11 BIOSTATUS LIMITED
    • TABLE 217 BIOSTATUS LIMITED: BUSINESS OVERVIEW
    • TABLE 218 BIOSTATUS LIMITED: PRODUCT OFFERINGS
    • 12.1.12 NANOCELLECT BIOMEDICAL
    • TABLE 219 NANOCELLECT BIOMEDICAL: BUSINESS OVERVIEW
    • TABLE 220 NANOCELLECT BIOMEDICAL: PRODUCT OFFERINGS
    • TABLE 221 NANOCELLECT BIOMEDICAL: DEALS
    • TABLE 222 NANOCELLECT BIOMEDICAL: PRODUCT LAUNCH
    • 12.1.13 CELL BIOLABS, INC.
    • TABLE 223 CELL BIOLABS, INC: BUSINESS OVERVIEW
    • TABLE 224 CELL BIOLABS, INC.: PRODUCT OFFERINGS
    • 12.1.14 CREATIVE BIOARRAY
    • TABLE 225 CREATIVE BIOARRAY: BUSINESS OVERVIEW
    • 12.1.15 MEIJI TECHNO
    • TABLE 226 MEIJI TECHNO: BUSINESS OVERVIEW
  • * Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 PROMEGA CORPORATION
    • TABLE 227 PROMEGA CORPORATION: COMPANY OVERVIEW
    • 12.2.2 PERKINELMER
    • TABLE 228 PERKINELMER: COMPANY OVERVIEW
    • 12.2.3 TECAN TRADING AG
    • TABLE 229 TECAN TRADING AG: COMPANY OVERVIEW
    • 12.2.4 CARL ZEISS
    • TABLE 230 CARL ZEISS: COMPANY OVERVIEW
    • 12.2.5 SYSMEX AMERICA, INC.
    • TABLE 231 SYSMEX AMERICA, INC.: COMPANY OVERVIEW
    • 12.2.6 CELLINK
    • TABLE 232 CELLINK: COMPANY OVERVIEW
    • 12.2.7 QIAGEN
    • TABLE 233 QIAGEN: COMPANY OVERVIEW
    • 12.2.8 ILLUMINA, INC.
    • TABLE 234 ILLUMINA, INC.: COMPANY OVERVIEW
    • 12.2.9 CORNING INCORPORATED
    • TABLE 235 CORNING INCORPORATED: COMPANY OVERVIEW
    • 12.2.10 10X GENOMICS
    • TABLE 236 10X GENOMICS: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS